vitalitiRX
loading weight loss
weight loss
Results without
the yo-yo.
GLP-1 based protocols with structured titration, built for adults who want a predictable taper — not a crash diet in a pen.
mission · 002
GLP-1 protocols with structured dose titration. Clinically validated dual- and triple-agonists. Lean-mass preserving. Designed for adults who want results without the yo-yo. Our catalog covers the dual-agonist with the clearest clinical track record — tirzepatide — and the triple-agonist investigational compound redefining the category, retatrutide. Studies have explored appetite regulation, insulin sensitivity, and, in the triple-agonist case, direct energy expenditure through glucagon receptor activity.
category data
- Peptides
- 2
- Protocols
- 2
- Avg ship
- 3–5 business days
- Verification
- HPLC ≥98%
the protocols
Two agonists.
2 / 2
Weight Loss
triple-agonist
Retatrutide
Appetite · Weight loss · Energy use
Three keys. Three receptors. One compound.
The newest, strongest weight-loss compound in trials
from
view →$114.99/mo
10mg · 20mg · 30mg
Weight Loss
dual-agonist
Tirzepatide
Appetite · Blood sugar · Weight loss
The dual-agonist with clinical track record.
The proven weight-loss compound with real-world data
from
view →$104.99/mo
10mg · 20mg · 30mg
how it fits · 3 steps
- step 01
Pick your agonist
Tirzepatide for a proven dual-agonist track record, or retatrutide for triple-receptor research.
- step 02
Subscribe monthly
Structured dose titration shipped on cadence so your protocol never stalls.
- step 03
Ships in 3–5 business days
Insulated mailer with courier across Canada. Tracking sent when the label prints.